Galactomannan clinical trials
Also written GM-CT-01 and DAVANAT.
How each study uses galactomannan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the galactomannan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2022 | 1 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 1
Galectin Therapeutics Inc. (4) · Bioxytran Inc. (2) · Children's Hospital of Fudan University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses galactomannan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and ProbioticsRecruitingNot applicableChildren's Hospital of Fudan UniversityNCT05791604Written as Prebiotics with galactomannan and oligofructose
- To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-MNot yet recruitingPhase 2Bioxytran Inc.NCT05733780Written as Prolectin-M
- PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19Status unknownPhase 3Bioxytran Inc.NCT05096052Written as Galactomannan
- A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal CancerWithdrawnPhase 2Galectin Therapeutics Inc.NCT00388700Written as GM-CT-01
- Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder CancerWithdrawnPhase 2Galectin Therapeutics Inc.NCT00386516Written as GM-CT-01
- Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid TumorsCompletedPhase 1Galectin Therapeutics Inc.NCT00054977Written as GM-CT-01
- GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal CancerTerminatedPhase 2Galectin Therapeutics Inc.NCT00110721Written as GM-CT-01 plus 5-Fluorouracil
Codes
What other systems call galactomannan · ClinicalTrials.gg INT002566
- MeSH (NLM) C012990galactomannanOne source NLM
- UNII (FDA) C2BXC3OWPADAVANATConfirmed FDA, NLM, Wikidata
- Wikidata Q106662952galactomannan CConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C91703Galactomannan DerivativeOne source FDA
- DrugBank DB15311One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C012990 | galactomannan | One source NLM |
| UNII (FDA) | C2BXC3OWPA | DAVANAT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q106662952 | galactomannan C | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C91703 | Galactomannan Derivative | One source FDA |
| DrugBank | DB15311 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.